Evidence-Based Reviews

Opioid use disorder in adolescents: An overview

Author and Disclosure Information

 

References

Screening for OUD

Several screening tools are available to assess adolescents for SUDs, including OUD.

CRAFFT is a 6-item, clinician-administered screening tool that has been approved by American Academy of Pediatrics’ Committee on Substance Abuse for adolescents and young adults age <21.21-23 This commonly used tool can assess for alcohol, cannabis, and other drug use. A score ≥2 is considered positive for drug use, indicating that the individual would require further evaluation and assessment22,23 (Figure). There is also a self-administered CRAFFT questionnaire that can be completed by the patient.

The CRAFFT Interview (Version 2.1) (Orally administered by clinician)

NIDA-modified ASSIST. The American Psychiatric Association has adapted the National Institute on Drug Abuse (NIDA)-modified ASSIST. One version is designated for parents/guardians to administer to their children (age 6 to 17), and one is designated for adolescents (age 11 to 17) to self-administer.24,25 Each screening tool has 2 levels: Level 1 screens for substance use and other mental health symptoms, and Level 2 is more specific for substance use alone.

Drug Use Screening Inventory (DUSI) is a self-report questionnaire that has 149 items that assess the use of numerous drugs. It is designed to quantify the severity of consequences associated with drug and alcohol use.26,27

Problem-Oriented Screening Instrument for Teenagers (POSIT) is a multidimensional tool that consists of 139 yes/no questions designed to explore adolescents’ (age 12 to 19 years) problem substance use and current functioning in other areas.28,29

Continue to: Personal Experience Screening Questionnaire (PESQ)...

Pages

Recommended Reading

Opioid reduction works after minimally invasive gynecologic surgery
Journal of Clinical Outcomes Management
A patient-centered approach to tapering opioids
Journal of Clinical Outcomes Management
Addiction specialists: Cannabis policies should go up in smoke
Journal of Clinical Outcomes Management
In addiction, abusive partners can wreak havoc
Journal of Clinical Outcomes Management
Dual e-cigarette and combustible tobacco use compound respiratory disease risk
Journal of Clinical Outcomes Management
FDA targets flavored cartridge-based e-cigarettes, but says it is not a ‘ban’
Journal of Clinical Outcomes Management
Adolescent alcohol, opioid misuse linked to risky behaviors
Journal of Clinical Outcomes Management
EVALI update warns of chemicals in vaping products
Journal of Clinical Outcomes Management
Opioid deaths boost donor heart supply
Journal of Clinical Outcomes Management
CDC: Opioid prescribing and use rates down since 2010
Journal of Clinical Outcomes Management